Product Information
GS NASAL FOUR 1% NASAL SPRAY is a generic product labeled by L. Perrigo Company, priced at $0.0672 per ML under NDC 00113064810. Its NADAC has been published 636 times since Nov 28, 2013.
Strength
1 g/100mL
Manufacturer
L. Perrigo CompanyNDC
00113064810
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/9/2002
Pharmacological Classes
Price Statistics
The NADAC for GS NASAL FOUR 1% NASAL SPRAY has been published 636 times since Nov 28, 2013, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0672 per ML |
|---|---|
| All-time high | $0.0874 (Mar 15, 2023) |
| All-time low | $0.0667 (Aug 20, 2014) |
| 52-week high | $0.0845 |
| 52-week low | $0.0672 |
| Median price | $0.0771 |
| Average price | $0.0779 |
| Largest weekly change | +15.6% (Nov 19, 2014) |
| Weeks tracked | 636 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenylephrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS NASAL FOUR 1% NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for GS NASAL FOUR 1% NASAL SPRAY, manufactured by L. Perrigo Company, is $0.0672 per ML (NDC 00113064810), effective Sep 30, 2026.
How has the price of GS NASAL FOUR 1% NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for GS NASAL FOUR 1% NASAL SPRAY has declined 12.7%. It has been tracked across 636 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GS NASAL FOUR 1% NASAL SPRAY?
Since Nov 28, 2013, the NADAC for GS NASAL FOUR 1% NASAL SPRAY has ranged from a low of $0.0667 (Aug 20, 2014) to a high of $0.0874 (Mar 15, 2023), with a median of $0.0771 per ML.
Are there cheaper alternatives to GS NASAL FOUR 1% NASAL SPRAY?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NASAL FOUR 1% NASAL SPRAY, is $0.0623 per ML — about 7% below GS NASAL FOUR 1% NASAL SPRAY.
Who manufactures GS NASAL FOUR 1% NASAL SPRAY?
GS NASAL FOUR 1% NASAL SPRAY (NDC 00113064810) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.